Physician profile
Usman Javed
NPI 1770592578
$20,287.26
in general payments reported to CMS, 2019-2025
18 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,779 · 2020: $1,468 · 2021: $1,082 · 2022: $11K · 2023: $553 · 2024: $1,752 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,432 · Travel and Lodging: $1,024 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,431.82 |
| Travel and Lodging | $1,024.15 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,779.77 | 2019-2025 | Mitraclip, Navitor, Triclip |
| Edwards Lifesciences Corporation | $3,433.72 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Amgen INC. | $868.89 | 2019-2021 | |
| Shockwave Medical, INC | $661.76 | 2019-2025 | |
| Abiomed | $569.21 | 2019-2022 | |
| Boston Scientific Corporation | $436.05 | 2019-2025 | Watchman Flx, Watchman, Farapulse |
| Novartis Pharmaceuticals Corporation | $399.96 | 2019-2020 | |
| Medtronic, INC. | $266.82 | 2021-2025 | Corevalve Evolut R, Venaseal |
| Astrazeneca Pharmaceuticals LP | $238.43 | 2019-2024 | Farxiga |
| Pfizer INC. | $147.63 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.51 | 2019-2021 | |
| Silk Road Medical, INC. | $131.46 | 2019 | |
| Cardiovascular Systems INC. | $93.43 | 2019-2022 | |
| Lundbeck LLC | $33.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.64 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $27.50 | 2025 | |
| Cook Medical LLC | $14.27 | 2022 | |
| Merck Sharp & Dohme LLC | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Javed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.